Pharmacy Search
Pharmacy Pharmacy
Most Read Articles
Ivermectin-doxycycline combo superior to monotherapy in severe rosacea
Stephen Padilla, 31 Jan 2020
The combination of ivermectin 1% cream (IVM) and doxycycline 40-mg modified-release capsules (DMR) delivers faster responses, better response rates and greater satisfaction compared with monotherapy in patients with severe rosacea, a recent study has shown.
Original New Drug Application Approvals by US FDA (16 - 31 May 2020)
02 Jun 2020
New drug applications approved by US FDA as of 16 - 31 May 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date. 
FDA-approved drug ivermectin kills SARS-CoV-2 in vitro
Stephen Padilla, 08 Apr 2020
An antiparasitic drug approved by the Food and Drug Administration (FDA) has been found to be effective in stopping the growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a laboratory experiment, according to a collaborative study.

Product Highlight - GALVUS MET

16 Sep 2020

As demonstrated by VERIFY study:

  • Early combination treatment strategy of Galvus Met was superior to standard of care metformin monotherapy: Offers 2 extra years of glycemic control1
  • Hypoglycemia and adverse event were not significantly increased with early initiation of Galvus Met vs metformin monotherapy1
  • Endorsed by ADA 2020 Guideline: Early treatment combination therapy can be considered at treatment initiation to extend the time to treatment failure in some patients2

 
References:
1) Matthews DR et al. Lancet. 2019;394:1519-1529;
2) American Diabetes Association. (2020). 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020.Diabetes Care,43(Supplement 1), S77-S88.
3) Prescribing information available at https://www.novartis.com.my/product-list-v2/products?sort_bef_combine=title+ASC&sort_bef_combine=title+ASC&combine=galvus+met

Related MIMS Drugs

GALVUS MET
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Ivermectin-doxycycline combo superior to monotherapy in severe rosacea
Stephen Padilla, 31 Jan 2020
The combination of ivermectin 1% cream (IVM) and doxycycline 40-mg modified-release capsules (DMR) delivers faster responses, better response rates and greater satisfaction compared with monotherapy in patients with severe rosacea, a recent study has shown.
Original New Drug Application Approvals by US FDA (16 - 31 May 2020)
02 Jun 2020
New drug applications approved by US FDA as of 16 - 31 May 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date. 
FDA-approved drug ivermectin kills SARS-CoV-2 in vitro
Stephen Padilla, 08 Apr 2020
An antiparasitic drug approved by the Food and Drug Administration (FDA) has been found to be effective in stopping the growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a laboratory experiment, according to a collaborative study.